Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
17 Nov 2020
Historique:
entrez: 17 11 2020
pubmed: 18 11 2020
medline: 1 12 2020
Statut: epublish

Résumé

Psychosis spectrum disorder has a complex pathoetiology characterised by interacting environmental and genetic vulnerabilities. The present study aims to investigate the role of gene-environment interaction using aggregate scores of genetic (polygenic risk score for schizophrenia (PRS-SCZ)) and environment liability for schizophrenia (exposome score for schizophrenia (ES-SCZ)) across the psychosis continuum. The sample consisted of 1699 patients, 1753 unaffected siblings, and 1542 healthy comparison participants. The Structured Interview for Schizotypy-Revised (SIS-R) was administered to analyse scores of total, positive, and negative schizotypy in siblings and healthy comparison participants. The PRS-SCZ was trained using the Psychiatric Genomics Consortiums results and the ES-SCZ was calculated guided by the approach validated in a previous report in the current data set. Regression models were applied to test the independent and joint effects of PRS-SCZ and ES-SCZ (adjusted for age, sex, and ancestry using 10 principal components). Both genetic and environmental vulnerability were associated with case-control status. Furthermore, there was evidence for additive interaction between binary modes of PRS-SCZ and ES-SCZ (above 75% of the control distribution) increasing the odds for schizophrenia spectrum diagnosis (relative excess risk due to interaction = 6.79, [95% confidential interval (CI) 3.32, 10.26], p < 0.001). Sensitivity analyses using continuous PRS-SCZ and ES-SCZ confirmed gene-environment interaction (relative excess risk due to interaction = 1.80 [95% CI 1.01, 3.32], p = 0.004). In siblings and healthy comparison participants, PRS-SCZ and ES-SCZ were associated with all SIS-R dimensions and evidence was found for an interaction between PRS-SCZ and ES-SCZ on the total (B = 0.006 [95% CI 0.003, 0.009], p < 0.001), positive (B = 0.006 [95% CI, 0.002, 0.009], p = 0.002), and negative (B = 0.006, [95% CI 0.004, 0.009], p < 0.001) schizotypy dimensions. The interplay between exposome load and schizophrenia genetic liability contributing to psychosis across the spectrum of expression provide further empirical support to the notion of aetiological continuity underlying an extended psychosis phenotype.

Identifiants

pubmed: 33200977
doi: 10.1017/S2045796020000943
pii: S2045796020000943
pmc: PMC7681168
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e182

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom

Investigateurs

Behrooz Z Alizadeh (BZ)
Therese van Amelsvoort (T)
Richard Bruggeman (R)
Wiepke Cahn (W)
Lieuwe de Haan (L)
Bart P F Rutten (BPF)
Jurjen J Luykx (JJ)
Jim van Os (J)
Ruud van Winkel (R)

Références

Int J Methods Psychiatr Res. 2012 Sep;21(3):205-21
pubmed: 22419500
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
JAMA Psychiatry. 2020 Aug 12;:
pubmed: 32805017
Schizophr Bull. 1989;15(4):559-71
pubmed: 2623438
Psychol Med. 2009 Feb;39(2):179-95
pubmed: 18606047
Am J Epidemiol. 1976 May;103(5):506-11
pubmed: 1274952
World Psychiatry. 2020 Jun;19(2):199-205
pubmed: 32394548
Acta Psychiatr Scand. 2020 May;141(5):465-475
pubmed: 32027017
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Int J Epidemiol. 2012 Apr;41(2):514-20
pubmed: 22253321
Schizophr Bull. 2020 Jul 8;46(4):1019-1025
pubmed: 32083289
Neurosci Biobehav Rev. 2016 Mar;62:1-20
pubmed: 26743858
World Psychiatry. 2018 Feb;17(1):49-66
pubmed: 29352556
Arch Gen Psychiatry. 1990 Jun;47(6):589-93
pubmed: 2190539
Schizophr Bull. 2018 Jun 6;44(4):710-719
pubmed: 29701807
Biol Psychiatry. 2018 Nov 1;84(9):684-691
pubmed: 29807621
Am J Epidemiol. 2017 Oct 1;186(7):778-786
pubmed: 28978190
Schizophr Res. 2013 Nov;150(2-3):356-65
pubmed: 24094883
JAMA Psychiatry. 2018 Jan 1;75(1):28-35
pubmed: 29167880
Int J Epidemiol. 2007 Oct;36(5):1111-8
pubmed: 17726040
Span J Psychol. 2004 May;7(1):3-12
pubmed: 15139244
Arch Gen Psychiatry. 1992 Aug;49(8):615-23
pubmed: 1637251
Schizophr Res. 2017 Nov;189:181-189
pubmed: 28179063
Hum Mol Genet. 2018 Aug 1;27(R2):R136-R152
pubmed: 29741616
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
pubmed: 1883262
J Interpers Violence. 2013 May;28(7):1498-518
pubmed: 23266990
Neuropsychopharmacology. 2011 Nov;36(12):2529-37
pubmed: 21775978
Psychol Med. 2020 Aug;50(11):1884-1897
pubmed: 31414981
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Psychol Med. 2019 Aug;49(11):1879-1889
pubmed: 30284529
World Psychiatry. 2019 Jun;18(2):173-182
pubmed: 31059627
Am J Psychiatry. 2004 Dec;161(12):2271-6
pubmed: 15569899
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Schizophr Bull. 2018 Feb 15;44(2):338-347
pubmed: 29036523
Psychol Med. 2018 Jan;48(2):229-244
pubmed: 28689498
JAMA Psychiatry. 2019 Jun 1;76(6):584-593
pubmed: 30892562
Psychopathology. 2006;39(4):175-8
pubmed: 16636640
Child Abuse Negl. 2009 Aug;33(8):518-23
pubmed: 19758699
Psychiatry Res. 2018 Jan;259:148-153
pubmed: 29049906
Transl Psychiatry. 2019 Jan 18;9(1):25
pubmed: 30659167
Schizophr Bull. 2000;26(3):619-29
pubmed: 10993402
Mol Psychiatry. 2018 Jul;23(7):1590-1596
pubmed: 28696435
Front Psychiatry. 2013 Oct 14;4:136
pubmed: 24133464
Schizophr Bull. 2003;29(3):587-93
pubmed: 14609251
Am J Epidemiol. 2009 Mar 15;169(6):756-60
pubmed: 19211620
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Curr Psychiatry Rep. 2019 Sep 14;21(10):100
pubmed: 31522306
Biol Psychiatry. 2018 Mar 15;83(6):492-498
pubmed: 28987712
Transl Psychiatry. 2019 Feb 4;9(1):14
pubmed: 30718454
Am J Hum Genet. 2008 Jul;83(1):132-5; author reply 135-9
pubmed: 18606306
Arch Gen Psychiatry. 1988 Dec;45(12):1069-77
pubmed: 2848472
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109910
pubmed: 32142745
Br J Psychiatry. 2010 Sep;197(3):170-1
pubmed: 20807958
Am J Epidemiol. 1980 Oct;112(4):467-70
pubmed: 7424895
Schizophr Bull. 2019 Sep 11;45(5):960-965
pubmed: 31508804
Schizophr Bull. 2018 Oct 17;44(6):1175-1179
pubmed: 30169883

Auteurs

L-K Pries (LK)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

G A Dal Ferro (GA)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

J van Os (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Psychiatry, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

P Delespaul (P)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
FACT, Mondriaan Mental Health, Maastricht, Netherlands.

G Kenis (G)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

B D Lin (BD)

Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

J J Luykx (JJ)

Department of Psychiatry, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
GGNet Mental Health, Apeldoorn, The Netherlands.

A L Richards (AL)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

B Akdede (B)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

T Binbay (T)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

V Altınyazar (V)

Department of Psychiatry, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.

B Yalınçetin (B)

Department of Neuroscience, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey.

G Gümüş-Akay (G)

Department of Physiology, School of Medicine, Ankara University, Ankara, Turkey.
Brain Research Center, Ankara University, Ankara, Turkey.

B Cihan (B)

Department of Psychology, Middle East Technical University, Ankara, Turkey.

H Soygür (H)

Turkish Federation of Schizophrenia Associations, Ankara, Turkey.

H Ulaş (H)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

E Şahin Cankurtaran (E)

Güven Çayyolu Healthcare Campus, Ankara, Turkey.

S Ulusoy Kaymak (S)

Atatürk Research and Training Hospital Psychiatry Clinic, Ankara, Turkey.

M M Mihaljevic (MM)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Clinic for Psychiatry Clinical Centre of Serbia, Belgrade, Serbia.

S Andric Petrovic (S)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Clinic for Psychiatry Clinical Centre of Serbia, Belgrade, Serbia.

T Mirjanic (T)

Special Hospital for Psychiatric Disorders Kovin, Kovin, Serbia.

M Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.

G Mezquida (G)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.

S Amoretti (S)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.

J Bobes (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

P A Saiz (PA)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

M Paz García-Portilla (MP)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

J Sanjuan (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.

E J Aguilar (EJ)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.

J L Santos (JL)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Virgen de la Luz, Cuenca, Spain.

E Jiménez-López (E)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Universidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain.

M Arrojo (M)

Department of Psychiatry, Instituto de Investigación Sanitaria, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

A Carracedo (A)

Grupo de Medicina Genómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Fundación Pública Galega de Medicina Xenómica (SERGAS), IDIS, Santiago de Compostela, Spain.

G López (G)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

J González-Peñas (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

M Parellada (M)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

N P Maric (NP)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Institute of Mental Health, Belgrade, Serbia.

C Atbaşoğlu (C)

Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.

A Ucok (A)

Department of Psychiatry, Faculty of Medicine, Istanbul University, Istanbul, Turkey.

K Alptekin (K)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Department of Neuroscience, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey.

M Can Saka (M)

Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.

C Arango (C)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

M O'Donovan (M)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

S Tosato (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.

B P F Rutten (BPF)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.

S Guloksuz (S)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH